Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in IntangiblesChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Lexaria Bioscience (LEXX) Exchange Rate Effect (2023 - 2026)

Lexaria Bioscience's Exchange Rate Effect history spans 4 years, with the latest figure at $20635.0 for Q1 2026.

  • Quarterly results put Exchange Rate Effect at $20635.0 for Q1 2026, up 121.66% from a year ago — trailing twelve months through Feb 2026 was $62802.0 (up 164.33% YoY), and the annual figure for FY2025 was -$50519.0, down 154.94%.
  • Exchange Rate Effect for Q1 2026 was $20635.0 at Lexaria Bioscience, up from -$5744.0 in the prior quarter.
  • In the past five years, Exchange Rate Effect ranged from a high of $37173.0 in Q2 2025 to a low of -$95255.0 in Q1 2025.
  • The 4-year median for Exchange Rate Effect is $405.0 (2024), against an average of -$5544.4.
  • Peak annual rise in Exchange Rate Effect hit 3097.82% in 2025, while the deepest fall reached 281.05% in 2025.
  • Year by year, Exchange Rate Effect stood at $4372.0 in 2023, then crashed by 172.62% to -$3175.0 in 2024, then plummeted by 80.91% to -$5744.0 in 2025, then soared by 459.24% to $20635.0 in 2026.
  • According to Business Quant data, Exchange Rate Effect over the past three periods came in at $20635.0, -$5744.0, and $10738.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.